Abstract
Gestational diabetes mellitus (GDM) is a metabolic disorder prevalent among pregnant women. This disease increases the risk of adverse perinatal outcomes and diseases in the offspring later in life. The human placenta, the main interface between the maternal and fetal blood circulations, is responsible for the maternal-to-fetal transfer of nutrients essential for fetal growth and development. In this context, the aim of this article is to review the latest advances in the placental transport of macro and micronutrients and how they are affected by GDM and its associated conditions, such as elevated levels of glucose, insulin, leptin, inflammation, and oxidative stress. Data analyzed in this article suggest that GDM and its associated conditions, particularly high levels of glucose, leptin, and oxidative stress, disturb placental nutrient transport and, consequently, fetal nutrient supply. As a consequence, this disturbance may contribute to the fetal and postnatal adverse health outcomes associated with GDM.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Negrato CA, Gomes MB. Historical facts of screening and diagnosing diabetes in pregnancy. Diabetol Metab Syndr. 2013;5:22. doi:10.1186/1758-5996-5-22.
Lappas M, Hiden U, Desoye G, Froehlich J, Hauguel-de Mouzon S, Jawerbaum A. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid Redox Signal. 2011;15:3061–100. doi:10.1089/ars.2010.3765.
Magon N, Chauhan M. Pregnancy in type 1 diabetes mellitus: how special are special issues? N Am J Med Sci. 2012;4:250–6. doi:10.4103/1947-2714.97202.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36:S67–74. doi:10.2337/dc13-S067. These useful guidelines provide definitions for the various types of diabetes, including gestational diabetes.
Shang M, Lin L. IADPSG criteria for diagnosing gestational diabetes mellitus and predicting adverse pregnancy outcomes. J Perinatol. 2014;34:100–4. doi:10.1038/jp.2013.143.
Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE, et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care. 2012;35:526–8. doi:10.2337/dc11-1641.
Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med. 2004;21:103–13. doi:10.1046/j.1464-5491.2003.00985.x.
Lepercq J, Cauzac M, Lahlou N, Timsit J, Girard J, Auwerx J, et al. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes. 1998;47:847–50. doi:10.2337/diabetes.47.5.847.
Ategbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab. 2006;91:4137–43. doi:10.1210/jc.2006-0980.
Guvener M, Ucar HI, Oc M, Pinar A. Plasma leptin levels increase to a greater extent following on-pump coronary artery surgery in type 2 diabetic patients than in nondiabetic patients. Diabetes Res Clin Pract. 2012;96:371–8. doi:10.1016/j.diabres.2012.01.008.
Plomgaard P, Nielsen AR, Fischer CP, Mortensen OH, Broholm C, Penkowa M, et al. Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia. 2007;50:2562–71. doi:10.1007/s00125-007-0834-6.
Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002. doi:10.1056/NEJMoa0707943.
Pettitt DJ, Lawrence JM, Beyer J, Hillier TA, Liese AD, Mayer-Davis B, et al. Association between maternal diabetes in utero and age at offspring’s diagnosis of type 2 diabetes. Diabetes Care. 2008;31:2126–30. doi:10.2337/dc08-0769.
Biri A, Korucuoglu U, Ozcan P, Aksakal N, Turan O, Himmetoglu O. Effect of different degrees of glucose intolerance on maternal and perinatal outcomes. J Matern Fetal Neonatal Med. 2009;22:473–8. doi:10.1080/14767050802610344.
Franks PW, Looker HC, Kobes S, Touger L, Tataranni PA, Hanson RL, et al. Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring. Diabetes. 2006;55:460–5. doi:10.2337/diabetes.55.02.06.db05-0823.
Takayama-Hasumi S, Yoshino H, Shimisu M, Minei S, Sanaka M, Omori Y. Insulin-receptor kinase is enhanced in placentas from non-insulin-dependent diabetic women with large-for-gestational-age babies. Diabetes Res Clin Pract. 1994;22:107–16. doi:10.1016/0168-8227(94)90043-4.
Coughlan MT, Vervaart PP, Permezel M, Georgiou HM, Rice GE. Altered placental oxidative stress status in gestational diabetes mellitus. Placenta. 2004;25:78–84. doi:10.1016/S0143-4004(03)00183-8.
Herrera E, Ortega-Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy—are these the cause of the problem? Best Pract Res Clin Endocrinol Metab. 2010;24:515–25. doi:10.1016/j.beem.2010.05.006.
Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359:61–73. doi:10.1056/NEJMra0708473.
Lee H, Jang HC, Park HK, Cho NH. Early manifestation of cardiovascular disease risk factors in offspring of mothers with previous history of gestational diabetes mellitus. Diabetes Res Clin Pract. 2007;78:238–45. doi:10.1016/j.diabres.2007.03.023.
Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115:e290–6. doi:10.1542/peds.2004-1808.
Ornoy A. Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes. Pediatr Endocrinol Rev. 2005;3:104–13.
Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care. 2007;30 Suppl 2:S251–60. doi:10.2337/dc07-s225.
Fowden AL, Forhead AJ, Coan PM, Burton GJ. The placenta and intrauterine programming. J Neuroendocrinol. 2008;20:439–50. doi:10.1111/j.1365-2826.2008.01663.x.
Jansson T, Myatt L, Powell TL. The role of trophoblast nutrient and ion transporters in the development of pregnancy complications and adult disease. Curr Vasc Pharmacol. 2009;7:521–33. doi:10.2174/157016109789043982.
Sandovici I, Hoelle K, Angiolini E, Constancia M. Placental adaptations to the maternal-fetal environment: implications for fetal growth and developmental programming. Reprod Biomed Online. 2012;25:68–89. doi:10.1016/j.rbmo.2012.03.017.
Avagliano L, Garo C, Marconi AM. Placental amino acids transport in intrauterine growth restriction. J Pregnancy. 2012;2012:972562. doi:10.1155/2012/972562.
Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36:62–7.
Lager S, Powell TL. Regulation of nutrient transport across the placenta. J Pregnancy. 2012;2012:179827. doi:10.1155/2012/179827. This article reviews in detail the regulation of placental nutrient transport by a wide variety of conditions.
Day PE, Cleal JK, Lofthouse EM, Hanson MA, Lewis RM. What factors determine placental glucose transfer kinetics? Placenta. 2013;34:953–8. doi:10.1016/j.placenta.2013.07.001.
Baumann MU, Deborde S, Illsley NP. Placental glucose transfer and fetal growth. Endocrine. 2002;19:13–22. doi:10.1385/ENDO:19:1:13.
Carter AM. Evolution of placental function in mammals: the molecular basis of gas and nutrient transfer, hormone secretion, and immune responses. Physiol Rev. 2012;92:1543–76. doi:10.1152/physrev.00040.2011. This review describes, from an evolutionary perspective, the structure and functions of the placenta.
Cleal JK, Lewis RM. The mechanisms and regulation of placental amino acid transport to the human foetus. J Neuroendocrinol. 2008;20:419–26. doi:10.1111/j.1365-2826.2008.01662.x.
Desforges M, Sibley CP. Placental nutrient supply and fetal growth. Int J Dev Biol. 2010;54:377–90. doi:10.1387/ijdb.082765md.
Lager S, Jansson N, Olsson AL, Wennergren M, Jansson T, Powell TL. Effect of IL-6 and TNF-alpha on fatty acid uptake in cultured human primary trophoblast cells. Placenta. 2011;32:121–7. doi:10.1016/j.placenta.2010.10.012.
Battaglia FC, Regnault TR. Placental transport and metabolism of amino acids. Placenta. 2001;22:145–61. doi:10.1053/plac.2000.0612.
Jansson T. Amino acid transporters in the human placenta. Pediatr Res. 2001;49:141–7. doi:10.1203/00006450-200102000-00003.
Ayuk PT, Sibley CP, Donnai P, D’Souza S, Glazier JD. Development and polarization of cationic amino acid transporters and regulators in the human placenta. Am J Physiol Cell Physiol. 2000;278:C1162–71.
Cunningham P, McDermott L. Long chain PUFA transport in human term placenta. J Nutr. 2009;139:636–9. doi:10.3945/jn.108.098608.
Duttaroy AK. Transport of fatty acids across the human placenta: a review. Prog Lipid Res. 2009;48:52–61. doi:10.1016/j.plipres.2008.11.001.
Haggarty P. Fatty acid supply to the human fetus. Annu Rev Nutr. 2010;30:237–55. doi:10.1146/annurev.nutr.012809.104742.
Solanky N, Requena Jimenez A, D’Souza SW, Sibley CP, Glazier JD. Expression of folate transporters in human placenta and implications for homocysteine metabolism. Placenta. 2010;31:134–43. doi:10.1016/j.placenta.2009.11.017.
Zhao R, Matherly LH, Goldman ID. Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues. Expert Rev Mol Med. 2009;11:e4. doi:10.1017/S1462399409000969.
Persson A, Johansson M, Jansson T, Powell TL. Na(+)/K(+)-ATPase activity and expression in syncytiotrophoblast plasma membranes in pregnancies complicated by diabetes. Placenta. 2002;23:386–91. doi:10.1053/plac.2002.0807.
Mitchell DM, Juppner H. Regulation of calcium homeostasis and bone metabolism in the fetus and neonate. Curr Opin Endocrinol Diabetes Obes. 2010;17:25–30. doi:10.1097/MED.0b013e328334f041.
Gonzalez-Perrett S, Kim K, Ibarra C, Damiano AE, Zotta E, Batelli M, et al. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci U S A. 2001;98:1182–7. doi:10.1073/pnas.021456598.
Brown K, Heller DS, Zamudio S, Illsley NP. Glucose transporter 3 (GLUT3) protein expression in human placenta across gestation. Placenta. 2011;32:1041–9. doi:10.1016/j.placenta.2011.09.014.
Desoye G, Gauster M, Wadsack C. Placental transport in pregnancy pathologies. Am J Clin Nutr. 2011;94:1896S–902. doi:10.3945/ajcn.110.000851.
Illsley NP. Glucose transporters in the human placenta. Placenta. 2000;21:14–22. doi:10.1053/plac.1999.0448.
Gaither K, Quraishi AN, Illsley NP. Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. J Clin Endocrinol Metab. 1999;84:695–701. doi:10.1210/jc.84.2.695.
Illsley NP, Sellers MC, Wright RL. Glycaemic regulation of glucose transporter expression and activity in the human placenta. Placenta. 1998;19:517–24. doi:10.1016/S0143-4004(98)91045-1.
Hahn T, Barth S, Weiss U, Mosgoeller W, Desoye G. Sustained hyperglycemia in vitro down-regulates the GLUT1 glucose transport system of cultured human term placental trophoblast: a mechanism to protect fetal development? FASEB J. 1998;12:1221–31.
Araújo JR, Pereira AC, Correia-Branco A, Keating E, Martel F. Oxidative stress induced by tert-butylhydroperoxide interferes with the placental transport of glucose: in vitro studies with BeWo cells. Eur J Pharmacol. 2013;720:218–26. doi:10.1016/j.ejphar.2013.10.023.
Lappas M, Andrikopoulos S, Permezel M. Hypoxanthine-xanthine oxidase down-regulates GLUT1 transcription via SIRT1 resulting in decreased glucose uptake in human placenta. J Endocrinol. 2012;213:49–57. doi:10.1530/JOE-11-0355.
Ericsson A, Hamark B, Jansson N, Johansson BR, Powell TL, Jansson T. Hormonal regulation of glucose and system A amino acid transport in first trimester placental villous fragments. Am J Physiol Regul Integr Comp Physiol. 2005;288:R656–62. doi:10.1152/ajpregu.00407.2004.
Araújo JR, Correia-Branco A, Pereira AC, Pinho MJ, Keating E, Martel F. Oxidative stress decreases uptake of neutral amino acids in a human placental cell line (BeWo cells). Reprod Toxicol. 2013;40C:76–81. doi:10.1016/j.reprotox.2013.06.073.
Jansson T, Ekstrand Y, Bjorn C, Wennergren M, Powell TL. Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes. 2002;51:2214–9. doi:10.2337/diabetes.51.7.2214.
Dicke JM, Henderson GI. Placental amino acid uptake in normal and complicated pregnancies. Am J Med Sci. 1988;295:223–7.
Araújo JR, Correia-Branco A, Ramalho C, Goncalves P, Pinho MJ, Keating E, et al. L-Methionine placental uptake: characterization and modulation in gestational diabetes mellitus. Reprod Sci. 2013;20:1492–507. doi:10.1177/1933719113488442.
von Versen-Hoynck F, Rajakumar A, Parrott MS, Powers RW. Leptin affects system A amino acid transport activity in the human placenta: evidence for STAT3 dependent mechanisms. Placenta. 2009;30:361–7. doi:10.1016/j.placenta.2009.01.004.
Nandakumaran M, Harouny AK, Al-Yatama M, Al-Azemi MK, Sugathan TN. Effect of increased glucose load on maternal-fetal transport of alpha-aminoisobutyric acid in the perfused human placenta: in vitro study. Acta Diabetol. 2002;39:75–81. doi:10.1007/s005920200017.
Jones HN, Jansson T, Powell TL. Full-length adiponectin attenuates insulin signaling and inhibits insulin-stimulated amino acid transport in human primary trophoblast cells. Diabetes. 2010;59:1161–70. doi:10.2337/db09-0824.
Jones HN, Jansson T, Powell TL. IL-6 stimulates system A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2. Am J Physiol Cell Physiol. 2009;297:C1228–35. doi:10.1152/ajpcell.00195.2009.
Nandakumaran M, Al-Shammari M, Al-Saleh E. Maternal-fetal transport kinetics of L-leucine in vitro in gestational diabetic pregnancies. Diabetes Metab. 2004;30:367–74.
Roos S, Powell TL, Jansson T. Human placental taurine transporter in uncomplicated and IUGR pregnancies: cellular localization, protein expression, and regulation. Am J Physiol Regul Integr Comp Physiol. 2004;287:R886–93. doi:10.1152/ajpregu.00232.2004.
Lee NY, Kang YS. Regulation of taurine transport at the blood-placental barrier by calcium ion, PKC activator and oxidative stress conditions. J Biomed Sci. 2010;17:S37. doi:10.1186/1423-0127-17-S1-S37.
Roos S, Lagerlof O, Wennergren M, Powell TL, Jansson T. Regulation of amino acid transporters by glucose and growth factors in cultured primary human trophoblast cells is mediated by mTOR signaling. Am J Physiol Cell Physiol. 2009;297:C723–31. doi:10.1152/ajpcell.00191.2009.
Keating E, Goncalves P, Campos I, Costa F, Martel F. Folic acid uptake by the human syncytiotrophoblast: interference by pharmacotherapy, drugs of abuse and pathological conditions. Reprod Toxicol. 2009;28:511–20. doi:10.1016/j.reprotox.2009.07.001.
Strid H, Bucht E, Jansson T, Wennergren M, Powell TL. ATP dependent Ca2+ transport across basal membrane of human syncytiotrophoblast in pregnancies complicated by intrauterine growth restriction or diabetes. Placenta. 2003;24:445–52.
Montalbetti N, Cantero MR, Dalghi MG, Cantiello HF. Reactive oxygen species inhibit polycystin-2 (TRPP2) cation channel activity in term human syncytiotrophoblast. Placenta. 2008;29:510–8. doi:10.1016/j.placenta.2008.02.015.
Burton G, Barker DJP, Moffett A, Thornburg KL. The placenta and human developmental programming. 1st ed. Cambridge: Cambridge University Press; 2011.
Jansson T, Ekstrand Y, Wennergren M, Powell TL. Placental glucose transport in gestational diabetes mellitus. Am J Obstet Gynecol. 2001;184:111–6. doi:10.1067/mob.2001.108075.
Bloxam DL, Bax CM, Bax BE. Culture of syncytiotrophoblast for the study of human placental transfer. Part I: isolation and purification of cytotrophoblast. Placenta. 1997;18:93–8. doi:10.1016/S0143-4004(97)90079-5.
Thongsong B, Subramanian RK, Ganapathy V, Prasad PD. Inhibition of amino acid transport system a by interleukin-1beta in trophoblasts. J Soc Gynecol Investig. 2005;12:495–503. doi:10.1016/j.jsgi.2005.06.008.
Bode CJ, Jin H, Rytting E, Silverstein PS, Young AM, Audus KL. In vitro models for studying trophoblast transcellular transport. Methods Mol Med. 2006;122:225–39. doi:10.1385/1-59259-989-3:225.
Kulkarni A, Dangat K, Kale A, Sable P, Chavan-Gautam P, Joshi S. Effects of altered maternal folic acid, vitamin B12 and docosahexaenoic acid on placental global DNA methylation patterns in Wistar rats. PLoS One. 2011;6:e17706. doi:10.1371/journal.pone.0017706.
Innis SM. Essential fatty acid transfer and fetal development. Placenta. 2005;26:S70–5. doi:10.1016/j.placenta.2005.01.005.
Larque E, Demmelmair H, Gil-Sanchez A, Prieto-Sanchez MT, Blanco JE, Pagan A, et al. Placental transfer of fatty acids and fetal implications. Am J Clin Nutr. 2011;94:1908S–13. doi:10.3945/ajcn.110.001230.
Ryan AS, Astwood JD, Gautier S, Kuratko CN, Nelson EB, Salem Jr N. Effects of long-chain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: a review of human studies. Prostaglandins Leukot Essent Fatty Acids. 2010;82:305–14. doi:10.1016/j.plefa.2010.02.007.
Greenberg JA, Bell SJ, Ausdal WV. Omega-3 fatty acid supplementation during pregnancy. Rev Obstet Gynecol. 2008;1:162–9.
Araújo JR, Correia-Branco A, Ramalho C, Keating E, Martel F. Gestational diabetes mellitus decreases placental uptake of long-chain polyunsaturated fatty acids: involvement of long-chain acyl-CoA synthetase. J Nutr Biochem. 2013;24:1741–50. doi:10.1016/j.jnutbio.2013.03.003.
Bonen A, Chabowski A, Luiken JJ, Glatz JF. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda). 2007;22:15–29.
Weedon-Fekjaer MS, Dalen KT, Solaas K, Staff AC, Duttaroy AK, Nebb HI. Activation of LXR increases acyl-CoA synthetase activity through direct regulation of ACSL3 in human placental trophoblast cells. J Lipid Res. 2010;51:1886–96. doi:10.1194/jlr.M004978.
Magnusson AL, Waterman IJ, Wennergren M, Jansson T, Powell TL. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab. 2004;89:4607–14. doi:10.1210/jc.2003-032234.
Radaelli T, Lepercq J, Varastehpour A, Basu S, Catalano PM, Hauguel-De Mouzon S. Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus. Am J Obstet Gynecol. 2009;201:209 e1–e10. doi:10.1016/j.ajog.2009.04.019.
Gauster M, Hiden U, van Poppel M, Frank S, Wadsack C, Hauguel-de Mouzon S, et al. Dysregulation of placental endothelial lipase in obese women with gestational diabetes mellitus. Diabetes. 2011;60:2457–64. doi:10.2337/db10-1434.
Pagan A, Prieto-Sanchez MT, Blanco-Carnero JE, Gil-Sanchez A, Parrilla JJ, Demmelmair H, et al. Materno-fetal transfer of docosahexaenoic acid is impaired by gestational diabetes mellitus. Am J Physiol Endocrinol Metab. 2013;305:E826–33. doi:10.1152/ajpendo.00291.2013.
Min Y, Lowy C, Ghebremeskel K, Thomas B, Bitsanis D, Crawford MA. Fetal erythrocyte membrane lipids modification: preliminary observation of an early sign of compromised insulin sensitivity in offspring of gestational diabetic women. Diabet Med. 2005;22:914–20. doi:10.1111/j.1464-5491.2005.01556.x.
Thomas BA, Ghebremeskel K, Lowy C, Offley-Shore B, Crawford MA. Plasma fatty acids of neonates born to mothers with and without gestational diabetes. Prostaglandins Leukot Essent Fatty Acids. 2005;72:335–41. doi:10.1016/j.plefa.2005.01.001.
Wijendran V, Bendel RB, Couch SC, Philipson EH, Cheruku S, Lammi-Keefe CJ. Fetal erythrocyte phospholipid polyunsaturated fatty acids are altered in pregnancy complicated with gestational diabetes mellitus. Lipids. 2000;35:927–31. doi:10.1007/S11745-000-0602-2.
Duttaroy AK, Jorgensen A. Insulin and leptin do not affect fatty acid uptake and metabolism in human placental choriocarcinoma (BeWo) cells. Prostaglandins Leukot Essent Fatty Acids. 2005;72:403–8. doi:10.1016/j.plefa.2005.03.004.
Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab. 2000;71:121–38. doi:10.1006/mgme.2000.3027.
Caballero B, Allen L, Prentice A. Encyclopedia of human nutrition. 2nd ed. Boston: Elsevier/Academic Press; 2005.
Zhao R, Diop-Bove N, Visentin M, Goldman ID. Mechanisms of membrane transport of folates into cells and across epithelia. Annu Rev Nutr. 2011;31:177–201. doi:10.1146/annurev-nutr-072610-145133.
Giugliani ER, Jorge SM, Goncalves AL. Serum and red blood cell folate levels in parturients, in the intervillous space of the placenta and in full-term newborns. J Perinat Med. 1985;13:55–9.
Hutson JR, Stade B, Lehotay DC, Collier CP, Kapur BM. Folic acid transport to the human fetus is decreased in pregnancies with chronic alcohol exposure. PLoS One. 2012;7:e38057. doi:10.1371/journal.pone.0038057.
Araújo JR, Correia-Branco A, Moreira L, Ramalho C, Martel F, Keating E. Folic acid uptake by the human syncytiotrophoblast is affected by gestational diabetes, hyperleptinemia, and TNF-alpha. Pediatr Res. 2013;73:388–94. doi:10.1038/pr.2013.14.
Torricelli M, Voltolini C, Bloise E, Biliotti G, Giovannelli A, De Bonis M, et al. Urocortin increases IL-4 and IL-10 secretion and reverses LPS-induced TNF-alpha release from human trophoblast primary cells. Am J Reprod Immunol. 2009;62:224–31. doi:10.1111/j.1600-0897.2009.00729.x.
Bardicef M, Bardicef O, Sorokin Y, Altura BM, Altura BT, Cotton DB, et al. Extracellular and intracellular magnesium depletion in pregnancy and gestational diabetes. Am J Obstet Gynecol. 1995;172:1009–13. doi:10.1016/0002-9378(95)90035-7.
Jansson T, Powell TL. Role of placental nutrient sensing in developmental programming. Clin Obstet Gynecol. 2013;56:591–601. doi:10.1097/GRF.0b013e3182993a2e. This article provides a simple description of how the fetoplacental unit responds to alterations in maternal nutrition and metabolism.
Acknowledgments
This work was supported by Fundação para a Ciência e a Tecnologia (FCT) and COMPETE, QREN, and FEDER (SFRH/BD/63086/2009).
Compliance with Ethics Guidelines
ᅟ
Conflict of Interest
João Ricardo Araújo, Elisa Keating, and Fátima Martel declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Diabetes and Pregnancy
Rights and permissions
About this article
Cite this article
Araújo, J.R., Keating, E. & Martel, F. Impact of Gestational Diabetes Mellitus in the Maternal-to-Fetal Transport of Nutrients. Curr Diab Rep 15, 1 (2015). https://doi.org/10.1007/s11892-014-0569-y
Published:
DOI: https://doi.org/10.1007/s11892-014-0569-y